Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Talaporfin

    ACTIVE PHARMA INGREDIENTS

    MARKET PLACE

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    28/10/2024 LIGHT SCIENCES ONCOLOGY INC
    U.S.A
    		 LIGHT SCIENCES ONCOLOGY INC 22405 TALAPORFIN SODIUM (LS11) LYOPHILIZED DRUG PRODUCT FORMULATION AND FILLING 2009-01-15 Active II N/A
    28/10/2024 LIGHT SCIENCES ONCOLOGY INC
    U.S.A
    		 LIGHT SCIENCES ONCOLOGY INC 18775 TALAPORFIN SODIUM (LS11) LYOPHILIZED DRUG PRODUCT 2005-09-15 Inactive II N/A